COVID-19 (Coronavirus)

Biobank at the Smidt Heart Institute

Condition: Heart failure


Key Inclusion Criteria

  • At least 18 years old
  • Heart failure, post-heart transplant patients, or normal controls (healthy subjects with no known heart disease) cared for by the Advanced Heart Disease Team at Cedars-Sinai Heart Institute

Key Exclusion Criteria

  • Patients with a hematocrit (HCT) less than 22
  • Children
  • Pregnancy

Full Study Name

Cedars-Sinai Heart Institute Biobank (IRB no. 32242)


The purpose of this study is to collect blood and tissue samples in a centralized bank that can be used for investigations. Participants have either been diagnosed with heart failure or may participate as a healthy volunteer.

Study samples will be used to conduct future research to improve diagnosis, treatment and assessments of disease risk and outcome in heart failure. Specimens collected for this study may also be valuable for teaching purposes or developing new diagnostics of heart failure.

Principal Investigator

Robin Shaw, MD, PhD


Eduardo Marbán, MD, PhD
Jon Kobashigawa, MD
Michele Hamilton, MD